{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:39:22Z","timestamp":1787585962298,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["2018-1-4201"],"award-info":[{"award-number":["2018-1-4201"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cryobiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cryobiol.2024.104864","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T02:18:40Z","timestamp":1708395520000},"page":"104864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Is cryoablation still suitable for advanced non-small cell lung cancer after failure of first-line chemotherapy? A multicenter, prospective, randomized-controlled trial of eighty-seven patients"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2915-5842","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueni","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanfang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinshu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houlin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cryobiol.2024.104864_bib26","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cryobiol.2024.104864_bib3","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1158\/1055-9965.EPI-14-0493","article-title":"Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010","volume":"11","author":"Cheng","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cryobiol.2024.104864_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12094-018-1978-1","article-title":"SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)","volume":"1","author":"Majem","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib4","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1200\/JCO.2010.32.6181","article-title":"Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas","volume":"15","author":"D'Angelo","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2017.77.0412","article-title":"Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer: results from the ca209-003 study","volume":"17","author":"Gettinger","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/annonc\/mds214","article-title":"Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-na\u00efve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)","volume":"1","author":"Inoue","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.hoc.2016.08.002","article-title":"Second-line chemotherapy and beyond for non-small cell lung cancer","volume":"1","author":"Durm","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cryobiol.2024.104864_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision diagnosis and treatment for advanced non-small-cell lung cancer","volume":"9","author":"Reck","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cryobiol.2024.104864_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-020-04091-3","article-title":"Comparison between single-agent and combination chemotherapy as second-line treatment for advanced non-small cell lung cancer: a multi-institutional retrospective analysis","volume":"1","author":"Yi","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/521691","article-title":"Cryoablation of early-stage primary lung cancer","author":"Inoue","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.cryobiol.2024.104864_bib22","article-title":"Oa12.03 percutaneous cryoablation for lung cancer patients for whom surgery or radiotherapy is contraindicated due to idiopathic pulmonary fibrosis","volume":"12","author":"Ohtsuka","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cryobiol.2015.06.004","article-title":"Non-extended cryoablation could be a new strategy in lung cancer management: an experiment on green fluorescent protein-labeled Lewis lung cancer-bearing mice","volume":"1","author":"Zhou","year":"2015","journal-title":"Cryobiology"},{"key":"10.1016\/j.cryobiol.2024.104864_bib31","doi-asserted-by":"crossref","first-page":"S705","DOI":"10.21037\/jtd.2016.09.42","article-title":"Percutaneous imaging-guided cryoablation for lung cancer","volume":"9","author":"Zhang","year":"2016","journal-title":"J Thorac Dis. Suppl"},{"key":"10.1016\/j.cryobiol.2024.104864_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/cryo.1998.2115","article-title":"Mechanisms of tissue injury in cryosurgery","volume":"3","author":"Gage","year":"1998","journal-title":"Cryobiology"},{"key":"10.1016\/j.cryobiol.2024.104864_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jtherbio.2019.05.023","article-title":"A study of heat transfer during cryosurgery of lung cancer","volume":"84","author":"Kumar","year":"2019","journal-title":"J. Therm. Biol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib5","first-page":"1031","article-title":"Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB\/IV non-small cell lung cancer","volume":"1","author":"Das","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cryobiol.2024.104864_bib12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.asjsur.2018.02.006","article-title":"The application effect of percutaneous cryoablation for the stage IIIB\/IV advanced non-small-cell lung cancer after the failure of chemoradiotherapy","volume":"6","author":"Gao","year":"2018","journal-title":"Asian J. Surg."},{"key":"10.1016\/j.cryobiol.2024.104864_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jtho.2018.01.017","article-title":"Immunological aspects of cryoablation of non-small cell lung cancer: a comprehensive review","volume":"5","author":"Katzman","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.950921","article-title":"Cryoablation and immune synergistic effect for lung cancer: a review","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.6004\/jnccn.2016.0031","article-title":"NCCN guidelines insights: non-small cell lung cancer, version 4.2016","volume":"3","author":"Ettinger","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cryobiol.2024.104864_bib14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","volume":"8","author":"Goldstraw","year":"2007","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"2","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cryobiol.2024.104864_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"6","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cryobiol.2014.05.007","article-title":"Combined therapy of percutaneous cryoablation and traditional Chinese medicine can be a promising strategy for elderly or advanced lung cancer patients based on a retrospective clinical study","volume":"1","author":"Gao","year":"2014","journal-title":"Cryobiology"},{"key":"10.1016\/j.cryobiol.2024.104864_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cryobiol.2023.104559","article-title":"Cryoablation combined with a clinical Chinese medicine for the treatment of lung cancer","volume":"112","author":"Wang","year":"2023","journal-title":"Cryobiology"},{"key":"10.1016\/j.cryobiol.2024.104864_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/1759-7714.13779","article-title":"Co-ablation versus cryoablation for the treatment of stage III-IV non-small cell lung cancer: a prospective, noninferiority, randomized, controlled trial (RCT)","volume":"4","author":"Yang","year":"2021","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.cryobiol.2024.104864_bib16","first-page":"3808","article-title":"Clinical observation on treating elder advanced non-small cell lung cancer with combination of Yangfei Formula and Ar-He targeted cryoablation","volume":"9","author":"He","year":"2016","journal-title":"China Journal of Traditional Chinese Medicine and Pharmacy"},{"key":"10.1016\/j.cryobiol.2024.104864_bib15","first-page":"228","article-title":"Clinical observation on Yangfei fomula's effect on reducing postoperative complications of elderly patients with advanced non-small cell lung cancer after argon-helium cryoablation","volume":"2","author":"He","year":"2016","journal-title":"WORLD CHINESE MEDICINE"},{"key":"10.1016\/j.cryobiol.2024.104864_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"5","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cryobiol.2024.104864_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0959-8049(94)90535-5","article-title":"The EORTC QLQ-LC13: a modular supplement to the EORTC Core quality of life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life","volume":"5","author":"Bergman","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cryobiol.2024.104864_bib33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11655-018-2988-0","article-title":"Green therapy of cancer: a promising grope for anticancer strategy by modern Chinese medicine","volume":"8","author":"Zhou","year":"2018","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.cryobiol.2024.104864_bib9","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1200\/JCO.2000.18.12.2354","article-title":"Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group","volume":"12","author":"Fossella","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cryobiol.2024.104864_bib24","first-page":"1674","article-title":"Prognostic factors of 112 elderly patients with advanced non-small cell lung cancer","volume":"6","author":"Ran","year":"2022","journal-title":"Pak J Med Sci"}],"container-title":["Cryobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011224024000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011224024000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:25:16Z","timestamp":1778711116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011224024000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":33,"alternative-id":["S0011224024000191"],"URL":"https:\/\/doi.org\/10.1016\/j.cryobiol.2024.104864","relation":{},"ISSN":["0011-2240"],"issn-type":[{"value":"0011-2240","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is cryoablation still suitable for advanced non-small cell lung cancer after failure of first-line chemotherapy? A multicenter, prospective, randomized-controlled trial of eighty-seven patients","name":"articletitle","label":"Article Title"},{"value":"Cryobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cryobiol.2024.104864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Cryobiology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104864"}}